tiprankstipranks
Oncology Pharma (ONPH)
OTHER OTC:ONPH
US Market

Oncology Pharma (ONPH) Income Statement

Compare
166 Followers

Oncology Pharma Income Statement

Last quarter (Q2 2023), Oncology Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Oncology Pharma's net income was $0.00. See Oncology Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -779.00$ -1.11K$ -1.11K
Operating Expenses
$ 0.00$ 62.05K$ 14.41M$ 402.77K$ 817.75K
Depreciation and Amortization
$ 228.49K$ 236.56K$ 779.00$ 1.11K$ 1.11K
EBITDA
$ 0.00$ -7.88K$ -14.66M$ -181.45K$ -817.75K
Operating Income
$ 0.00$ -62.05K$ -14.41M$ -403.88K$ -818.86K
Other Income/Expenses
$ 0.00$ -104.56M$ -83.06M$ 196.33K$ -31.53K
Pretax Income
$ 0.00$ -104.63M$ -97.47M$ -207.56K$ -850.40K
Net Income
$ 0.00$ -104.63M$ -97.47M$ -207.56K$ -850.40K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ -3.42$ -6.76$ -0.12$ -0.72
Diluted EPS
$ 0.00$ -3.42$ -6.76$ -0.12$ -0.72
Weighted Average Shares Outstanding
38.56M 30.55M 14.42M 1.68M 1.19M
Weighted Average Shares Outstanding (Diluted)
38.56M 30.55M 14.42M 1.68M 1.19M
Currency in USD

Oncology Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis